Form 8.3 - Horizon Therapeutics plc

Contacts

Contacts

Contacts

Search

April 11, 2023 10:25 AM Eastern Daylight Time

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	10^th April 2023

2. INTERESTS AND SHORT POSITIONS

a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,278,748 (1.870%)		23,323 (0.010%)
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	578,800 (0.253%)		1,201,500 (0.525%)
Total	4,857,548 (2.123%)		1,224,823 (0.535%)

b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Ap20

1. DEALINGS (Note 4)

a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Sale	45	109.73
Sale	147	109.38
Sale	120	109.49
Sale	501	109.66
Sale	214	109.26
Sale	22	109.15
Sale	5,192	109.55
Sale	82	109.57
Sale	2,000	109.30
Sale	300	108.90
Sale	2,162	109.34
Sale	10	109.42
Sale	130	109.63
Sale	813	109.46
Sale	639	109.67
Sale	523	109.60
Sale	12,772	109.61
Sale	133	109.32
Sale	3,214	109.41
Sale	2,099	109.20
Sale	301	109.62
Sale	49	109.59
Sale	10	109.53
Sale	421	109.58
Sale	1	109.54
Sale	4,240	109.56
Sale	117	109.68
Sale	604	109.65
Sale	50	109.64
Sale	6,729	109.43
Sale	200	109.66
Sale	51	109.57
Purchase	966	109.30
Sale	5	109.42
Sale	99	109.40
Sale	28	109.50
Sale	275	109.60
Sale	138	109.61
Sale	122	109.32
Sale	65	109.41
Sale	100	109.59
Sale	6	109.65
Sale	5	109.44
Purchase	40	109.30
Sale	1,212	109.30
Sale	40	109.72
Purchase	100	109.38
Purchase	32	108.83
Purchase	686	108.91
Purchase	317	109.48
Purchase	100	109.09
Purchase	800	109.06
Purchase	631	109.35
Purchase	3,043	109.55
Purchase	224	109.57
Purchase	1,156	109.30
Purchase	300	108.90
Purchase	1,124	109.10
Purchase	104	109.34
Purchase	622	109.42
Purchase	400	108.88
Purchase	1,096	109.63
Purchase	1,013	109.46
Purchase	130	109.28
Purchase	100	108.87
Purchase	1,147	109.02
Purchase	200	109.67
Purchase	1,546	109.40
Purchase	700	109.00
Purchase	688	109.37
Purchase	350	108.99
Purchase	298	109.50
Purchase	943	109.01
Purchase	100	109.60
Purchase	360	109.32
Purchase	415	109.41
Purchase	374	108.89
Purchase	1	109.62
Purchase	300	109.39
Purchase	483	109.36
Purchase	100	109.59
Purchase	10	109.53
Sale	2	109.53
Purchase	100	109.58
Purchase	3,230	109.47
Purchase	110	109.54
Purchase	4,440	109.56
Purchase	250	109.29
Purchase	300	109.65
Purchase	213	109.31
Purchase	504	109.64
Purchase	110	109.27

b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

c) Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	11^th April 2023
Contact name	Sirina Kumar
Telephone number	+44 203 192 8741
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Written	198,900	90.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	11,500	110.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Written	262,400	115.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	42,500	120.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	5,200	110.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	2,900	80.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	221,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	254,200	100.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Purchased	5,200	105.00	American	4/21/2023
IE00BQPVQZ61	Call Option	Written	100,000	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Written	103,400	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	155,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	200,000	100.00	American	8/18/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1080052

Time of Receipt (offset from UTC): 20230411T143345+0100

Millennium Partners, L.P.

Class of relevant security:

Number

Number

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell